Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sumita Ray

General Counsel at Cue Biopharma, Inc. (CUE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $317K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 14SEC CUECue Biopharma, Inc. Sell 1,844116,701 held (−2%) $28.05 $52K -40.4%
Aug 17SEC CUECue Biopharma, Inc. Sell 2,383124,991 held (−2%) $29.37 $70K -43.1%
Aug 17SEC CUECue Biopharma, Inc. Sell 6,442118,549 held (−5%) $30.35 $196K -44.9%
Aug 17SEC CUECue Biopharma, Inc. Sell 4118,545 held (−0%) $31.13 $125 -46.3%